
Elizabeth Fox MD
Associate Professor, Pediatrics, Perelman School of Medicine
Join to view full profile
St. Jude Children's Research Hospital262 Danny Thomas PlaceMemphis, TN 38105
Dr. Fox is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1996 - 1999
University of Rochester Medical CenterResidency, Pediatrics, 1993 - 1996
Pennsylvania State University College of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 2020 - 2027
PA State Medical License 2010 - 2021
MD State Medical License 1998 - 2010
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 26
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Publications & Presentations
PubMed
- Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.Susanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, Michael V Ortiz, Ronald Bernardi
JCO Precision Oncology. 2026-01-01 - 1 citationsA Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, Gregory K Friedman, James M Croop
Pediatric Blood & Cancer. 2025-07-01 - 10 citationsEfficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions.Ami V Desai, Aditi Bagchi, Amy E Armstrong, Cornelis M van Tilburg, Ellen M Basu
European Journal of Cancer. 2025-05-02
Press Mentions
Few Pediatric Cancer Drugs Reach Phase 3 or ApprovalMay 16th, 2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









